April 15, 2020 Imperial welcomes world-leading health, research and education designation Imperial College Academic Health Science Centre has been redesignated an AHSC for a further five years. The prestigious designation from the National Institute of Health Research and NHS England/Improvement recognises Imperial College AHSC as a centre of excellence in health research, education and patient care. The Imperial College AHSC is a University-NHS partnership that aims to accelerate the translation of scientific breakthroughs into […]
March 3, 2020 Better children’s health and cancer treatment amongst aims of health partnership Professor Jonathan Weber has outlined his new vision for Imperial College Academic Health Science Centre (AHSC) over the next five years. The AHSC is a unique partnership between Imperial College London, The Institute of Cancer Research (ICR), Imperial College Healthcare NHS Trust, The Royal Marsden NHS Foundation Trust and the Royal Brompton & Harefield NHS […]
October 25, 2018 Triple combination of drugs shows encouraging trial results for cystic fibrosis A combination of three drugs has been used to target the most common genetic mutation responsible for cystic fibrosis in patients for the first time. In the trial, patients who received one new drug as well as two existing drugs had a significant improvement in lung function compared to patients taking the two existing tablets […]